Molecular Mechanisms of Cell Death.
In plain English
AI plain-English summaryCells in the body commit suicide on a precise schedule, and when that schedule goes wrong, tissues either accumulate too many cells—as in cancer—or lose too many, as in neurodegenerative disease. This research tackles a fundamental gap in knowledge: how cells decide whether to die by apoptosis (the orderly, programmed death) or by necroptosis (a more recently discovered, inflammatory form of death). Many existing drugs, including chemotherapies, trigger these death pathways as a side effect, causing toxicity in healthy tissues like the heart or liver. Without a clear understanding of the molecular switches involved, drug developers cannot predict which patients will suffer harm or how to design safer treatments. The project aims to map the core proteins and pathways that govern these two death modes in normal and diseased cells. If successful, it will produce predictive models of mitochondrial toxicity—a common reason drugs fail in trials or are withdrawn after approval. This would allow pharmaceutical companies to screen out dangerous compounds earlier, and could also point to ways to reduce the toxic side effects of current treatments. This is fundamental science. It does not promise an immediate new drug. But understanding the basic mechanics of cell death has, in the past, led directly to therapies such as targeted cancer drugs that switch cell death back on in tumours.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
IntramuralPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know